Formononetin Regulates Multiple Oncogenic Signaling Cascades and Enhances Sensitivity to Bortezomib in a Multiple Myeloma Mouse Model
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Formononetin Regulates Multiple Oncogenic Signaling Cascades and Enhances Sensitivity to Bortezomib in a Multiple Myeloma Mouse Model
Authors
Keywords
-
Journal
Biomolecules
Volume 9, Issue 7, Pages 262
Publisher
MDPI AG
Online
2019-07-08
DOI
10.3390/biom9070262
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma
- (2019) Lei Wang et al. ONCOLOGY REPORTS
- Targeting signaling pathways in multiple myeloma: Pathogenesis and implication for treatments
- (2018) Jingping Hu et al. CANCER LETTERS
- Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model
- (2018) Chulwon Kim et al. CANCER LETTERS
- Various Signaling Pathways in Multiple Myeloma Cells and Effects of Treatment on These Pathways
- (2018) Ali Dehghanifard et al. Clinical Lymphoma Myeloma & Leukemia
- Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention
- (2018) Devesh Tewari et al. PHARMACOLOGICAL RESEARCH
- Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies
- (2018) Praful Ravi et al. Blood Cancer Journal
- Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma
- (2018) Muthu K. Shanmugam et al. Frontiers in Pharmacology
- Oleuropein induces apoptosis via abrogating NF-κB activation cascade in estrogen receptor-negative breast cancer cells
- (2018) Lian Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies
- (2018) Kerrie Faia et al. PLoS One
- Copanlisib, a novel phosphoinositide 3-kinase inhibitor, combined with carfilzomib inhibits multiple myeloma cell proliferation
- (2018) Seiichi Okabe et al. ANNALS OF HEMATOLOGY
- Overexpression of HIF-1α contributes to melphalan resistance in multiple myeloma cells by activation of ERK1/2, Akt, and NF-κB
- (2018) Masanobu Tsubaki et al. LABORATORY INVESTIGATION
- 2,5-Dihydroxyacetophenone Induces Apoptosis of Multiple Myeloma Cells by Regulating the MAPK Activation Pathway
- (2017) Jeong-Hyeon Ko et al. MOLECULES
- Formononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN
- (2017) Yiying Wu et al. Food & Function
- Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress
- (2017) Craig T. Wallington-Beddoe et al. Oncotarget
- Mangiferin enhances the sensitivity of human multiple myeloma cells to anticancer drugs through suppression of the nuclear factor κB pathway
- (2016) TOMOYA TAKEDA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Thromboxane A2Receptor Inhibition Suppresses Multiple Myeloma Cell Proliferation by Inducing p38/c-Jun N-terminal Kinase (JNK) Mitogen-activated Protein Kinase (MAPK)-mediated G2/M Progression Delay and Cell Apoptosis
- (2016) Qian Liu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment
- (2016) F Fan et al. LEUKEMIA
- NF-κB in cancer therapy
- (2015) Feng Li et al. ARCHIVES OF TOXICOLOGY
- Analysis of the intricate relationship between chronic inflammation and cancer
- (2015) Edna Zhi Pei Chai et al. BIOCHEMICAL JOURNAL
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Farnesol inhibits tumor growth and enhances the anticancer effects of bortezomib in multiple myeloma xenograft mouse model through the modulation of STAT3 signaling pathway
- (2015) Jong Hyun Lee et al. CANCER LETTERS
- Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer
- (2015) Kanjoormana A. Manu et al. CANCER LETTERS
- Formononetin inhibits enterovirus 71 replication by regulating COX- 2/PGE2 expression
- (2015) Huiqiang Wang et al. Virology Journal
- Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
- (2015) Shikha Satendra Singh WORLD JOURNAL OF GASTROENTEROLOGY
- Garcinol sensitizes human head and neck carcinoma to cisplatin in a xenograft mouse model despite downregulation of proliferative biomarkers
- (2015) Feng Li et al. Oncotarget
- γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model
- (2015) Kodappully Sivaraman Siveen et al. Oncotarget
- Formononetin Promotes Cell Cycle Arrest via Downregulation of Akt/Cyclin D1/CDK4 in Human Prostate Cancer Cells
- (2014) Tianyu Li et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation.
- (2014) J Picot et al. HEALTH TECHNOLOGY ASSESSMENT
- Formononetin Inhibits Migration and Invasion of MDA-MB-231 and 4T1 Breast Cancer Cells by Suppressing MMP-2 and MMP-9 Through PI3K/AKT Signaling Pathways
- (2014) R. Zhou et al. HORMONE AND METABOLIC RESEARCH
- Current treatment landscape for relapsed and/or refractory multiple myeloma
- (2014) Meletios A. Dimopoulos et al. Nature Reviews Clinical Oncology
- Involvement of p38 MAPK in haemozoin-dependent MMP-9 enhancement in human monocytes
- (2013) Amina Khadjavi et al. CELL BIOCHEMISTRY AND FUNCTION
- Selaginella tamariscina (Beauv.) possesses antimetastatic effects on human osteosarcoma cells by decreasing MMP-2 and MMP-9 secretions via p38 and Akt signaling pathways
- (2013) Jia-Sin Yang et al. FOOD AND CHEMICAL TOXICOLOGY
- Formononetin Inhibited the Inflammation of LPS-Induced Acute Lung Injury in Mice Associated with Induction of PPAR Gamma Expression
- (2013) Zhanqiang Ma et al. INFLAMMATION
- Current Therapeutic Strategy for Multiple Myeloma
- (2013) Kenshi Suzuki JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Neuroprotective Effects of Formononetin Against NMDA-Induced Apoptosis in Cortical Neurons
- (2013) Zhen Tian et al. PHYTOTHERAPY RESEARCH
- MEK inhibitors as a chemotherapeutic intervention in multiple myeloma
- (2013) C Chang-Yew Leow et al. Blood Cancer Journal
- A Small Molecule Inhibitor of Ubiquitin-Specific Protease-7 Induces Apoptosis in Multiple Myeloma Cells and Overcomes Bortezomib Resistance
- (2012) Dharminder Chauhan et al. CANCER CELL
- First Evidence That -Tocotrienol Inhibits the Growth of Human Gastric Cancer and Chemosensitizes It to Capecitabine in a Xenograft Mouse Model through the Modulation of NF- B Pathway
- (2012) K. A. Manu et al. CLINICAL CANCER RESEARCH
- Novel anti-angiogenic effects of formononetin in human colon cancer cells and tumor xenograft
- (2012) KATHY KA-WAI AUYEUNG et al. ONCOLOGY REPORTS
- Multifaceted link between cancer and inflammation
- (2011) Gautam Sethi et al. BIOSCIENCE REPORTS
- Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
- (2011) A. Palumbo et al. BLOOD
- Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
- (2011) Radhamani Kannaiyan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4
- (2011) Kanjoormana Manu et al. Molecular Cancer
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting transcription factor NF-κB to overcome chemoresistance and radioresistance in cancer therapy
- (2010) Feng Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Formononetin accelerates wound repair by the regulation of early growth response factor-1 transcription factor through the phosphorylation of the ERK and p38 MAPK pathways
- (2010) Jeong-Eun Huh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Bortezomib induces canonical nuclear factor- B activation in multiple myeloma cells
- (2009) T. Hideshima et al. BLOOD
- Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model
- (2009) B. Sung et al. MOLECULAR CANCER THERAPEUTICS
- Potential pharmacological control of the NF-κB pathway
- (2009) Gautam Sethi et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Multiple myeloma
- (2008) R. A. Kyle et al. BLOOD
- Natural Products as Leads to Potential Drugs: An Old Process or the New Hope for Drug Discovery?
- (2008) David J. Newman JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now